ClinicalTrials.gg

Program

ZM-H1505R

Also written as “ZM-H1505R 100mg”.

Its studies are mostly in Hepatitis B, Chronic, led by Shanghai Zhimeng Biopharma.

Furthest: phase 3, since Jul 14, 20254 company-led studies, 1 open or runningNext primary completion: Jan 2028 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Shanghai Zhimeng Biopharma41 open or runningphase 3since Jul 14, 2025Dec 23, 2019Jan 2028phase 3 · NCT07095855

Also a collaborator on its studies: Tigermed Consulting.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Dec 23, 2019First study: phase 1 study in Healthy VolunteersFirst studyNCT04220801 · 64 enrolled · United States
  2. Jul 18, 2022Phase 1 study in Hepatitis B, ChronicNCT05470829 · 42 enrolled · China
  3. Jul 20, 2022Phase 2 study in Hepatitis B, ChronicNCT05484466 · 90 enrolled · China
  4. Jul 14, 2025Phase 3 study in Hepatitis B, ChronicNCT07095855 · 1,300 planned · China

Ahead

  1. Jan 2028Primary completion: phase 3 study in Hepatitis B, ChronicNCT07095855

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07095855Hepatitis B, Chronic · China3Not yet recruitingJan 20281,300
NCT05484466Hepatitis B, Chronic · China2UNKNOWNDec 20, 202290
NCT05470829Hepatitis B, Chronic · China1CompletedNov 17, 202142
NCT04220801Healthy Volunteers · United States1CompletedNov 18, 202064

How it is read

Names in the registry

  • “ZM-H1505R”, 3 entries
  • “ZM-H1505R 100mg”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.